News
Sally Susman says there's no average day in her field and explains why she doesn't see comms as a 'soft skill.' ...
Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...
Alliance today announced a new direct-to-patient option for purchasing Eliquis ® (apixaban) via our Alliance’s patient resource Eliquis 360 Support. The offering provides an opportunity for uninsured, ...
3d
Barchart on MSNThis Blue-Chip Stock Is 20% Off Its Highs. Should You Buy the Dip?Pfizer (PFE), a global pharmaceutical giant that was once a pandemic darling, is now facing turbulence. Following a period of extraordinary vaccine-driven revenue, the company now faces a more ...
In an industry that’s long been run by storied Hollywood executives, those with backgrounds in finance and dealmaking are ...
WASHINGTON, DC / ACCESS Newswire / July 15, 2025 /FairWinds Partners, the world's leading domain name strategy consultancy, ...
In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine was viable.
Detailed price information for Iovance Biotherapeutics Inc (IOVA-Q) from The Globe and Mail including charting and trades.
The label expansion sought by GSK is a bid to compete with Pfizer and Moderna in the younger age groups of the RSV vaccine market. Pfizer’s Abrysvo and Moderna’s mRESVIA are both approved to prevent ...
The e-commerce giant has been working on an overhaul for the past several months without conducting any broad layoffs as part of its reorganization.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results